SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
jnc12108-sup-0001-FigS1-S2.pdfPDF document1426K

Figure S1. Inhibition of AMPK activation with compound C inhibits MCL-1 activation.

Figure S2. AICAR treatment does not alter NMDA receptor NR2A and 2B protein levels.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.